News Releases

11/22/21

Neuronetics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference

11/09/21

Neuronetics Reports Third Quarter 2021 Financial and Operating Results

11/08/21

Neuronetics and River Region Psychiatry Announce Exclusive Partnership

10/26/21

Neuronetics to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call

10/26/21

Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS

10/19/21

CORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021

10/19/21

Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health

10/12/21

Neuronetics Announces Preliminary Revenue for Third Quarter 2021

10/05/21

Neuronetics Announces Commercial Agreement with Success TMS

10/04/21

NeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch

09/22/21

UPDATE - New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS

09/21/21

New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS

09/07/21

Neuronetics and Zion Healing Announce First Franchise Model for TMS Clinics

08/17/21

Neuronetics Launches New Website to Meet Patient Demand for Depression Resources

08/05/21

Neuronetics Announces Appointment of Megan Rosengarten to its Board of Directors

08/03/21

Neuronetics Reports Second Quarter 2021 Financial and Operating Results

07/29/21

Neuronetics to Present at the Canaccord Genuity 41st Annual Growth Conference

07/20/21

Neuronetics to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call

07/14/21

Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers

06/23/21

Neuronetics Set to Join Russell 2000® Index

06/09/21

Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting

06/03/21

Neuronetics to Present at The JMP Securities Life Sciences Conference

06/01/21

Neuronetics Names Todd Cushman as Vice President, Business Development

04/20/21

Neuronetics to Report First Quarter 2021 Financial and Operating Results and Host Conference Call

04/14/21

Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors

04/01/21

Neuronetics Announces Appointment of Robert Cascella to its Board of Directors

03/11/21

Neuronetics Announces Retirement of Gregory Harper, Vice President, R&D and Clinical

03/09/21

Neuronetics Enhances TrakStar® Cloud Patient Data Management System to Maximize Physician Efficiencies

03/03/21

Neuronetics Names Cory Anderson Vice President, Clinical Affairs and Medical Operations

03/02/21

Neuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating Results

02/23/21

NeuroStar® Advanced Therapy Outcomes Registry Clinical Data Published in Brain Stimulation Validates Depression Treatment Protocols

02/16/21

Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference Call

02/11/21

Neuronetics Announces Strategic Leadership Promotions to Support Future Growth

02/10/21

Neuronetics to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

02/02/21

Neuronetics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

01/28/21

Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock

01/28/21

Neuronetics Announces Proposed Public Offering of Common Stock

01/19/21

NeuroStar® Advanced Therapy’s Depression Outcomes Registry Hits 10,000 Patient Milestone

01/12/21

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results

01/07/21

Neuronetics to Participate at the 23rd Annual ICR Westwicke Conference

01/07/21

Neuronetics Announces Expansion of Sales Organization